Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal RNA-processing protein 7 homolog A (RRP7A) is a nucleolar RNA-binding protein essential for the maturation of ribosomal RNA, the assembly of the ribosome’s small subunit processome, and for ribosome biogenesis. RRP7A is involved in the resorption of primary cilia and cell cycle progression, particularly in neurogenesis and development of the neocortex. Mutations in RRP7A cause defects in ribosomal RNA processing and cell cycle regulation, leading to primary autosomal recessive microcephaly characterized by reduced brain size and cognitive impairment. RRP7A localizes to centrosomes, cilia, and nucleoli, integrating functions crucial for neural tissue development. No therapeutics currently target RRP7A directly, but its genetic status serves as a cause and marker for specific developmental brain disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal RNA-processing protein 7 homolog A (RRP7A).